News Releases Year: All News2020201920182017201620152014201320122011 Items per page All News2550 June 3, 2020 Summary ToggleAllena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Read more May 26, 2020 Summary ToggleAllena Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference Read more May 13, 2020 Summary ToggleAllena Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update Read more March 16, 2020 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Provides Business Update Read more February 24, 2020 Summary ToggleAllena Pharmaceuticals to Present at 40th Annual Cowen & Co. Health Care Conference Read more February 12, 2020 Summary ToggleAllena Pharmaceuticals Announces Streamlined Design for URIROX-2, Second Pivotal Clinical Trial of Reloxaliase for Enteric Hyperoxaluria Read more December 4, 2019 Summary ToggleAllena Pharmaceuticals Provides Updates on Reloxaliase Development Program and Corporate Activities Read more November 25, 2019 Summary ToggleAllena Pharmaceuticals to Present at Evercore ISI 2nd Annual HEALTHCONx Conference Read more November 13, 2019 Summary ToggleAllena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update Read more November 7, 2019 Summary ToggleAllena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206 Read more Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
